Phase III

Davis JC, van der Heijde DM, Braun J, Dougados M, Clegg D, Inman RD, Kivitz A, Fleischmannn R, Inman R, Ni L, Lin S, Tsuji W.
 Efficacy and safety of up to 192 Weeks of etanercept in patients with ankylosing spondylitis.
Ann Rheum Dis. 2007; 66(Suppl. 11):393 (Abstract)

Inman RD, Clegg DO, Davis JC, Whitmore JB, Solinger A
 Etanercept in adult patients with early onset ankylosing spondylitis
J Rheumatol. 2006 Aug;33(8):1634-6

Davis JC Jr, Van der Heijde DM, Dougados M, Braun J, Cush JJ, Clegg DO, Inman RD, de Vries T, Tsuji WH
 Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept
J Rheumatol. 2005 Sep;32(9):1751-4

Davis JC, van der Heijde DM, Braun J, Dougados M, Cush J, Clegg D, Inman RD, Kivitz A, Zhou L, Solinger A, Tsuji W.
 Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
Ann Rheum Dis. 2005; 64(11):1557-62

Baraliakos X, Brandt J, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.
 Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
Arthritis Rheum. 2005 Dec 15;53(6):856-63.

Baraliakos X, Davis J, Tsuji W, Braun J
 Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein Etanercept
Arthritis Rheum. 2005 Apr;52(4):1216-23.

Davis JC, van der Heijde D, Dougados M, Woolley JM.
 Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy
Arthritis Rheum. 2005; 53(4):494-501

Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmartí R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM, Fatenejad S.
 Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
Ann Rheum Dis. 2004 Dec;63(12):1594-600

Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W.
 Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis Rheum 2003; 48: 3230-3236